Brief: Vvt Med Expands European Commercial Footprint Through Exclusive Distribution Agreement In Greece
BRIEF-Vvt Med Expands European Commercial Footprint Through Exclusive Distribution Agreement In Greece June 26 (Reuters) - VVT Med Inc VVTM.V:
VVT MED EXPANDS EUROPEAN COMMERCIAL FOOTPRINT THROUGH EXCLUSIVE DISTRIBUTION AGREEMENT IN GREECE
VVT MED - GCP GRANTED EXCLUSIVE DISTRIBUTION RIGHTS FOR SCLEROSAFE IN GREECE FOR FIVE YEARS
VVT MED - AGREEMENT INCLUDES MINIMUM PURCHASE COMMITMENTS OF €712,800 OVER FIVE YEARS
Source text: ID:nCNWTVblPa
Further company coverage: VVTM.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VVT Med
See all newsBrief: VVT Med Establishes Exclusive Canadian Commercial Partnership With Chs For Sclerosafe®
Brief: VVT Med Closes Second Tranche Of Private Placement Of Units Over $1.8M In Total Proceeds Raised
Brief: Vvt Med Expands European Commercial Footprint Through Exclusive Distribution Agreement In Greece
Brief: VVT Med Provides Update On Management Cease Trade Order
Brief: VVT Med Receives Order From Major Us Healthcare Network Northwell Health And Enters Into Investor Relations Agreements